Barbara De Buono, MD, Mph
About Barbara De Buono, MD, Mph
Barbara De Buono, MD, MPH, serves as a Professorial Lecturer in the Department of Health Policy at George Washington University and as a Clinical Advisor at the New York City Department of Health. She has extensive experience in public health, having held leadership roles in various organizations, including Pfizer, Merck, and 3M Health Care.
Current Role at The George Washington University
Barbara De Buono serves as a Professorial Lecturer in the Department of Health Policy at George Washington University Milken School of Public Health. She has held this position since 2009, contributing to the academic community for over 15 years. In her role, she engages in teaching and mentoring students in health policy, drawing from her extensive experience in public health and healthcare management.
Professional Experience in Public Health
Barbara De Buono has a diverse background in public health, having served in various leadership roles. Currently, she is a Clinical Advisor at the New York City Department of Health, a position she has held since 2021. Previously, she worked at 3M Health Care as Vice President of Value Based Solutions from 2013 to 2021, and at Pfizer as Executive Director of Public Health and Government from 2000 to 2008. Her experience includes significant roles in both the public and private sectors.
Educational Background and Qualifications
Barbara De Buono earned her Doctor of Medicine (MD) degree from the University of Rochester School of Medicine and Dentistry, completing her studies from 1976 to 1980. She furthered her education at Harvard T.H. Chan School of Public Health, where she obtained a Master of Public Health (MPH) degree in 1984. Her educational background supports her expertise in health policy and public health.
Previous Leadership Roles
Throughout her career, Barbara De Buono has held several notable leadership positions. She served as Commissioner of Health for the New York State Department of Health from 1994 to 1998. Additionally, she was a Global Director of Health and Social Marketing at Porter Novelli from 2009 to 2011 and a Consultant at Merck in 2012. Her leadership roles have contributed to her extensive knowledge in health systems and policy.
Expertise in Health Policy and COVID-19 Response
Barbara De Buono possesses expertise in provider/payer led ACO transformation and Medicaid and state government health policy. She has played a significant role in the COVID-19 response, serving as a vaccination advisor and administrator in New York City and upstate New York counties. Her involvement includes conducting COVID vaccine breakthrough case investigations and cluster investigations in various settings.